Affymetrix will seek to add targeting genotyping technology to its portfolio in an effort to cast a wider net in the genomic tools market, according a company official.
Chief Financial Officer John Batty said last week that the GeneChip vendor is seeking to “acquire technology that will allow us to compete in the broader genetic analysis market.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.